NCT03070353View on ClinicalTrials.gov

Dextran, a Plasma Expander, Offers New Hope for Patients With Decompensated Liver Cirrhosis and Acute Kidney Injury

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

July 1, 2015

Primary Completion Date

June 30, 2016

Study Completion Date

June 30, 2016

Conditions
Cirrhosis, LiverAKI
Interventions
DRUG

Dextran 40

Dextran-40 infusion with the dose of 1 g/kg/day (10 ml/kg/day) for 2 days.

All Listed Sponsors
lead

Ramathibodi Hospital

OTHER

NCT03070353 - Dextran, a Plasma Expander, Offers New Hope for Patients With Decompensated Liver Cirrhosis and Acute Kidney Injury | Biotech Hunter | Biotech Hunter